Navigation Links
Putting a bull's-eye on the flu: Detailing influenza's structure for drug targeting
Date:10/21/2010

Beating the flu is already tough, but it has become even harder in recent years the influenza A virus has mutated so that two antiviral drugs don't slow it down anymore.

Reporting their findings in the journal Science, researchers from Florida State and Brigham Young move closer to understanding why not, and how future treatments can defeat the nasty bug no matter how it changes.

The two drugs, amantadine and rimantadine, are no longer recommended by the CDC for use against flu.

They used to work by blocking a hole in the influenza A virus called the "M2 channel," which plays a key role in the virus's ability to reproduce. When the channel changed ever so slightly at the atomic level, the virus became resistant to the drugs.

The research team used a 16-ton magnet to give the virus what amounts to an MRI, and they determined the tiniest, heretofore unknown details of the structure of this channel. The next step is to find a new way to block it.

"This work is laying a foundation to understand how that mutation does its damage and then of course how we can respond with a new bullet," said David Busath, a biophysicist at BYU and co-author of the paper. "Now we've got a fine enough resolution on the target we can start shooting at it, so to speak."

All versions of the flu virus have an M2 channel, so that makes it an attractive potential "Achilles' heel" drugs can aim for.

Another appeal of the channel as a drug target is that there are only a limited number of ways it could mutate in the future and continue to function. So it's possible that blockers could be identified in advance to defeat the virus no matter how it changes.

Because the channel's parts are so minute they cannot be seen with even an electron microscope, the researchers rely on a 15-foot-tall battery of electromagnets super-cooled by liquid nitrogen, supervised by Timothy A. Cross, a Florida State scientist and se
'/>"/>

Contact: Joseph Hadfield
joseph_hadfield@byu.edu
801-422-9206
Brigham Young University
Source:Eurekalert  

Page: 1 2

Related biology technology :

1. Researchers putting a freeze on oscillator vibrations
2. Putting the squeeze on an old material could lead to instant on electronic memory
3. Putting a new spin on current research
4. Intricate, curving 3-D nanostructures created using capillary action forces
5. New computer-tomography method visualizes nano-structure of bones
6. High-speed filter uses electrified nanostructures to purify water at low cost
7. Federal grant invests in nanostructured super materials
8. Unprecedented look at oxide interfaces reveals unexpected structures on atomic scale
9. Empa grows sea urchin-shaped structures
10. Depth charge: Using atomic force microscopy to study subsurface structures
11. Researchers use X-ray diffraction microscope to reveal 3-D internal structure of whole cell
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Putting a bull's-eye on the flu: Detailing influenza's structure for drug targeting
(Date:1/22/2015)... , a precision medicine software company that has developed a ... genomic, imaging and other biomedical data in research and clinical ... CEO of Aspera, an IBM Company, to its board as ... "We are pleased to welcome Michelle to ...
(Date:12/24/2014)... Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... MDT ) has submitted a pre-market approval application ... the use of Medtronic,s SynchroMed ® II implantable ... use with United Therapeutics, Remodulin ® (treprostinil) Injection ...
(Date:12/24/2014)... Wash. , Dec. 24, 2014   BioLife Solutions , ... and marketer of proprietary clinical grade hypothermic storage ... shipping products for cells and tissues  ("BioLife" or the ... Meeting of Stockholders on May 4, 2015 (the "Annual Meeting"). ...
(Date:12/24/2014)... 23, 2014 Earlier this year in a ... of the Adult Stem Cell Technology Center, LLC ( ASCTC ... unique property of adult tissue stem cells. His title ... Important for the Future,” embodied the essence of his message ...
Breaking Biology Technology:GenoSpace Expands Board with Appointment of Michelle Munson 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4BioLife Solutions Sets Date for Annual Meeting of Stockholders 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4
... TORONTO, Sept. 15, 2011 Generex Biotechnology Corporation ... update on the status of the previously announced ... ( www.antigenexpress.com ). The Company is ... review of several transaction opportunities, including both shell ...
... and SYDNEY, Sept. 14, 2011 HeartWare International, Inc. ... leading innovator of less invasive, miniaturized circulatory support technologies ... today announced that CEO Doug Godshall is scheduled to ... 10:30 a.m. ET on Wednesday, September 21, 2011.  The ...
... 2011 Tengion, Inc. (NASDAQ: TNGN ), a ... President Finance and Chief Financial Officer of Tengion, will present ... September 19, 2011, at 1:30 pm EDT. ... "Calendar of Events" in the Investors section of the Company,s ...
Cached Biology Technology:Generex Provides Update on Spinout of Antigen Express 2Generex Provides Update on Spinout of Antigen Express 3Generex Provides Update on Spinout of Antigen Express 4HeartWare to Present at the UBS Global Life Sciences Conference 2Tengion to Present at UBS Global Life Sciences Conference 2
(Date:1/22/2015)... 2015  A man-made form of insulin delivered by nasal ... in adults with mild cognitive impairment and Alzheimer,s disease ... at Wake Forest Baptist Medical Center. The ... cognitive impairment (MCI) or mild to moderate Alzheimer,s dementia ...
(Date:1/22/2015)... Issued by Small Cap IR. In 2011, Nilson Report,s annual ... merchants on the leading payment cards rose to $135.3 billion ... prepaid cards reached 6.54 billion.  Eight million credit card users ... 2012, and credit and debit card fraud resulted in $11.27 ...
(Date:1/22/2015)... NEW YORK , Jan. 22, 2015   EyeLock, Inc. ... announced it has appointed Steve Gerber to the ... Gerber will be responsible for leading development of mobile platforms ... 25 years of success and innovation in the semiconductor industry ...
Breaking Biology News(10 mins):Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 2
... January 11, 2010 The subtle but ongoing pressures of ... as autism, autoimmune diseases, and reproductive cancers, researchers write in ... Certain adaptations that once benefited humans may now be ... because of advancements in modern culture and medicine. ...
... , REDWOOD CITY, Calif. and ... in fingerprint identity and authentication solutions, has extended its ... Retail Anywhere , a leading developer of point-of-sale (POS) ... in North America, has integrated U.are.U® fingerprint ...
... significantly enhance household incomes and nutritional intake of ... new Stanford University study published in the Proceedings ... two-year study found that solar-powered pumps installed in ... Benin were a cost-effective way of delivering much-needed ...
Cached Biology News:Ongoing human evolution could explain recent rise in certain disorders 2Retail Anywhere Adds U.are.U Biometrics From DigitalPersona to Flagship Point of Sale Solution 2Retail Anywhere Adds U.are.U Biometrics From DigitalPersona to Flagship Point of Sale Solution 3Solar-powered irrigation significantly improves diet and income in rural sub-Saharan Africa 2Solar-powered irrigation significantly improves diet and income in rural sub-Saharan Africa 3Solar-powered irrigation significantly improves diet and income in rural sub-Saharan Africa 4
LabFax: Immunochemistry...
Mycoplasma Removal Agent (MRA) has been developed for cell culture, to combat the widespread problems caused by contamination of cell cultures with mycoplasma....
Request Info...
albumin from bovine serum (BSA), BODIPY® FL conjugate...
Biology Products: